|
|
Post by letitride on Feb 12, 2020 21:46:48 GMT -5
I am along for the ride I am not steering the ship. I do not believe this is about MC.
Sorry about the typo have a little patience.
Lets Go!
|
|
|
|
Post by mytakeonit on Feb 12, 2020 22:07:02 GMT -5
Well letitride ... welcome to the poop list. Since we are brothers now, can I ride on your boat and car? BTW, CC is coming soon to a theater near you.
But, that's mytakeonit
|
|
|
|
Post by rockstarrick on Feb 12, 2020 22:10:36 GMT -5
Return prescriptions have been rising, but I’m not sure it’s enough to comment on, or if mnkd has even noticed, or knows the significance of it. There are definitely more PWD refilling their prescriptions so retention is slowly improving, but I doubt we here anything from mnkd until the TRX #’s are over 1000/week, and RRX’s are at least 70%. That will be a great accomplishment imo, and could happen in 2020 if we are just a little lucky. Mike needs to be talking about Afrezza and TS, he should be in the public’s eye as much as possible. These appearances at Healthcare Conferences do nothing to let the public know about us, and those attending these conferences already know about mnkd. The general public doesn’t know we exist for the most part. More patients refilling would happen unless long term retention was basically zero. One would need to look deeper into the data to validate whether retention is improving, and I don't think it would be easy developing a valid model for the data analysis, though I'd be curious if anyone has actually crunched numbers. Wow, I certainly would hope MNKD is aware of the retention rate. I've certainly never been in the "gotta replace management" camp, but if they haven't noticed or don't recognize the significance of retention rate, I'd vote in a heart beat to replace them. Though, I'm quite confident they are competent and follow it closely. This would be 1 week, not the best, just the first I came to in my search. But NRx #’s have consistently been in the 300+ range, while the rrx have trailed until recently. The growth at the end of 2019 was return prescriptions, if the TRX are growing, and NRx aren’t, the difference has to be retention, or rrx. And I’m sure mnkd is tracking, I was being a smart ass to put it bluntly, but until we reach that 1000 TRX mark with 70% retention, I doubt we hear much. There may have been a higher rrx count, the week we had record TRX perhaps, but for the week of 1/17/2019 is a fair example. mnkd.proboards.com/thread/2679/symphony-script-data?page=138✌🏻😎 |
|
|
|
Post by prcgorman2 on Feb 13, 2020 7:28:25 GMT -5
Retention is a combination of two main factors; quality of experience, insurance coverage. Many posters have implied that Mannkind diabetes educators are incompetent and only the experts at VDEX know the secret sauce required to ensure quality of experience. My sentiment is that is not likely. mnholdem used to track Afrezza tier placement in the insurance formularies and post his findings. I think he gave up doing that a long time ago. My sentiment is the big nut to crack for retention is insurance coverage.
|
|
|
|
Post by sportsrancho on Feb 13, 2020 7:33:41 GMT -5
Retention is a combination of two main factors; quality of experience, insurance coverage. Many posters have implied that Mannkind diabetes educators are incompetent and only the experts at VDEX know the secret sauce required to ensure quality of experience. My sentiment is that is not likely. mnholdem used to track Afrezza tier placement in the insurance formularies and post his findings. I think he gave up doing that a long time ago. My sentiment is the big nut to crack for retention is insurance coverage. . I didn’t hear anybody saying the diabetic educator’s at Mannkind were incompetent, quite the opposite. I know a few reps and they are great...what I said about Vdex was their protocols are different because they can prescribe off label. And that makes dosing much easier to understand. And it gives you quicker results and therefore the insurance is easier to get covered. |
|
|
|
Post by prcgorman2 on Feb 13, 2020 7:36:09 GMT -5
Retention is a combination of two main factors; quality of experience, insurance coverage. Many posters have implied that Mannkind diabetes educators are incompetent and only the experts at VDEX know the secret sauce required to ensure quality of experience. My sentiment is that is not likely. mnholdem used to track Afrezza tier placement in the insurance formularies and post his findings. I think he gave up doing that a long time ago. My sentiment is the big nut to crack for retention is insurance coverage. . I didn’t hear anybody saying the diabetic educator’s at Mannkind were incompetent, quite the opposite. I know a few reps and they are great...what I said about Vdex was their protocols are different because they can prescribe off label. And that makes dosing much easier to understand. And it gives you quicker results and therefore the insurance is easier to get covered. I am sure you are right. |
|
|
|
Post by rfogel on Feb 13, 2020 8:43:25 GMT -5
Retention is a combination of two main factors; quality of experience, insurance coverage. Many posters have implied that Mannkind diabetes educators are incompetent and only the experts at VDEX know the secret sauce required to ensure quality of experience. My sentiment is that is not likely. mnholdem used to track Afrezza tier placement in the insurance formularies and post his findings. I think he gave up doing that a long time ago. My sentiment is the big nut to crack for retention is insurance coverage. . I didn’t hear anybody saying the diabetic educator’s at Mannkind were incompetent, quite the opposite. I know a few reps and they are great...what I said about Vdex was their protocols are different because they can prescribe off label. And that makes dosing much easier to understand. And it gives you quicker results and therefore the insurance is easier to get covered. Does Mannkind employ certified diabetic educators or does it rely on the sales people? Isn't there a risk that sales people handing out medical advice could produce malpractice liability issues? |
|
|
|
Post by prcgorman2 on Feb 13, 2020 9:46:14 GMT -5
Which do you think is cheaper, CDEs or salespeople? It has also been mentioned here (where there are pumpers, bashers, aka liars) that some of the salespeople are persons with diabetes.
|
|
|
|
Post by pguererro on Feb 13, 2020 10:50:57 GMT -5
At least 10% of the sales force are type 1’s and using Afrezza. In many cases they are able share their life changing experiences with their own personal Endo and he/she STILL wouldn’t write Afrezza. So frustrating.
|
|
|
|
Post by brotherm1 on Feb 13, 2020 10:50:58 GMT -5
Liars? Ouch. Sounds a little harsh. I think if any posters on this board misspoke the truth, it’ has not been intentional. If they have, they appear to be weeded out quickly as I’m not seeing it.
|
|
|
|
Post by ktim on Feb 13, 2020 15:07:57 GMT -5
Retention is a combination of two main factors; quality of experience, insurance coverage. Many posters have implied that Mannkind diabetes educators are incompetent and only the experts at VDEX know the secret sauce required to ensure quality of experience. My sentiment is that is not likely. mnholdem used to track Afrezza tier placement in the insurance formularies and post his findings. I think he gave up doing that a long time ago. My sentiment is the big nut to crack for retention is insurance coverage. Not exactly sure how and when a patient might interact with a Mannkind diabetes educator, but I believe the first line of education would be a staff member of the doctor's office or clinic to which the patient goes, who may or may not have had training from Mannkind. At least that is my understanding. I'm sure some of the high prescribing non VDex doctors may do good jobs at patient onboarding, but also wouldn't be surprised that some may be less good. Hard to know where the barriers are since management doesn't believe in candor on these issues. We're left speculating about the problems and speculating as to whether management's plans and actions will address them. |
|
|
|
Post by sportsrancho on Feb 13, 2020 15:16:46 GMT -5
Liars? Ouch. Sounds a little harsh. I think if any posters on this board misspoke the truth, it’ has not been intentional. If they have, they appear to be weeded out quickly as I’m not seeing it. I’m confused, what was the lie? |
|
|
|
Post by lifebreath on Feb 13, 2020 15:32:51 GMT -5
Which do you think is cheaper, CDEs or salespeople? It has also been mentioned here (where there are pumpers, bashers, aka liars) that some of the salespeople are persons with diabetes. this is the claim of liars post Sports |
|
|
|
Post by sportsrancho on Feb 13, 2020 16:37:34 GMT -5
Which do you think is cheaper, CDEs or salespeople? It has also been mentioned here (where there are pumpers, bashers, aka liars) that some of the salespeople are persons with diabetes. this is the claim of liars post Sports I know Mannkind has sales reps that are type one diabetic‘s. |
|
|
|
Post by akemp3000 on Feb 14, 2020 17:19:43 GMT -5
Ok. 38 yes votes and 33 no votes. Only four days remaining to solve this once and for all  |
|
